Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has issued an announcement.
PharmaCorp Rx Inc. has announced the filing of its audited financial statements and MD&A for the year ending December 31, 2024, on SEDAR+. This move reflects the company’s ongoing commitment to transparency and regulatory compliance, potentially enhancing its credibility and attractiveness to investors as it continues its expansion strategy in the Canadian pharmacy market.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates three PharmaChoice bannered pharmacies in Canada and plans to continue acquiring both PharmaChoice Canada branded and independently owned pharmacies to operate under the PharmaChoice Canada banner. The company is listed on the TSX Venture Exchange under the symbol PCRX.
YTD Price Performance: 9.09%
Average Trading Volume: 20,670
Technical Sentiment Signal: Hold
Current Market Cap: C$50.41M
Learn more about PCRX stock on TipRanks’ Stock Analysis page.